Get started

Snap

$USRM From .0045 Onwards She is Ready for the 4th Leg UpBy far one of my top 3 favorite stocks so far this year, our Bio baby has proven her stamina. She has hit the .08 support at triple bottom and is ready for a 4th massive move upwards. With Institutional investors now throwing upwards of $5 million in financing at her for a stake in what is to be a potential FDA approval after a more than likely RMAT approval, its no wonder she is up almost 20,000% as of today from where we first found her. This is a perfect time to get back in if you already sold and are looking for another entry point for the next leg up.
OTC:USRMLong
by StockGuild
$OWCP Why I'm Extremely Long on This $5.00 by EOMI was in on the initial run .0030 - .10 bought and sold from .10 - $3.00 bought and sold (both times sold too early) and now .50 - $5.00 Here's why: PROVISIONAL PATENTS TAKE ABOUT 8-12 MONTHS TO GET TURNED INTO APPROVED PATENTS. Here's the list of $OWCP Patents: 1) patentscope.wipo.int 2) patentscope.wipo.int 3) patentscope.wipo.int 4) patentscope.wipo.int 5) patentscope.wipo.int 6) patentscope.wipo.int 7) patentscope.wipo.int Also the Patent Document: www.docdroid.net FROM THE 8K ON APRIL 4TH: OWC Pharmaceutical Research Corp. ("OWC") is reporting the issuance on April 5, 2017 of the attached press release, announcing that as a result of the promising conclusions reported in its Form 8-K filed on March 20, 2017, the Company has received expressions of scientific and medical interest, world-wide, for its cannabinoid-based topical cream for treating psoriasis. OWCP has expanded the size and scope of its clinical studies and, as previously announced, anticipates that subject to pending regulatory approvals from applicable jurisdictions, the topical cream should be available for use by those who suffer from psoriasis in the near term. ALSO LETS NOT FORGET 4/20 In addition we have many news outlets covering MJ which is bringing it back into the light. CANADA LEGALIZING IT NATIONWIDE. Too many catalysts to cover. Once we break key resistance tomorrow we could see $2.00 by EOD
OTC:OWCPLong
by StockGuild
SNAP - Potential of two centerlines?I had right now a fellow trader asking me about which centerlines could be met, if I have two forks on the chart. The answer is: either of both can be met, even if the other one is a very big one like the one in the current Gold chart: Why is this possible? It is a question of the perspective, the context: If you look for "quickies", then you probably prefer to trade the smaller ones, because the TIME it takes to reach the centerline of the smaller fork is shorter, even if both have the 80% chance to be hit. So, think first what you can stand, what your style of trading really is and with what product you trade it. And by "product" I mean the underlying or options or futures etc. I like to trade options very much. But I seldom only buy options, I look for theta - time decay and collect premium. If my assumption of a market is heavily directional, then I use options too, playing my chances with a RiskReversal (Selling options for a premium which finances me the bought options, that are usually two or more times the bought ones.) Go slow, learn (by asking like this trader) and then you will earn...it's a process and it takes time. P!
NYSE:SNAPShort
by Tr8dingN3rd
SNAP - Down to the centerline and the the bounce?Here is a new view about SNAP. We made money on the last two trades (up and down) and now we must wait and be patient. I see the centerline as potential place where this stock can bounce back - how far? Dunno... But since the confidence is getting crunched more and more, it's also possible that we see a zoom through the centerline, with a following test/retest back to it and then a very sharp continuation to the downside...but this just the possible scenario that plays in my brain. First we just observe and and see, if SNAP can find supporters at the centerline. P!
NYSE:SNAPLong
by Tr8dingN3rd
Good FB buying opportunityWith NYSE:SNAP entering the market we see Facebook accelerating the addition of new features to become more competitive. Facebook has massive resources at its disposal to fight off any new market upstart and the threat of SNAP taking away market share will be excellent motivation for the young yet experienced Zuckerberg, to hold on to his dominant market position. The recent dip pushed NASDAQ:FB into oversold territory which presents us with a good buying opportunity.
NASDAQ:METALong
by DaHunt
$USRM Alerted from .012 Currently on 3rd Major Breakout Setup$USRM is currently awaiting RMAT designation which approved (And there is a 90% or higher chance it will) gives it similar qualities as Breakthrough Therapy, Accelerated Approval, and Priority Review. Basically, they can provisionally approve the drug or device for marketing and then provided the drug or device proves safe and reasonably effective, they will gain full approval - generally within 6 months. Other DD: 1. Institutional Loading 2. Multiple Patents 3. Nice ER that showed substantial profits 4. PreClinical Study Results Anyday 5. Form 4s filed by insiders 6. Uplistment
OTC:USRMLong
by StockGuild
$IDXG On The Run Again and this time it will be sustainedLet's recap $IDXG CC: 1. New York State and AETNA approvals of ThyraMIR®, microRNA assay 2. Talked about the Debt being restructured 3. No more offerings 4. Reduced operating costs 5. Talks of doing business with their BarreGen model 6. Talks of partnering with another bio he didn't discuss. 7. EPS value of $3.25 vs -($12.04) same quarter last year 8. Sales of $3.122 million. 9. Goldman, Rodman and Renshaw, Barclays were on the CC too big boys will be here soon enough count on it. 10. 64% of the S/S is SHORT 11. Raised $14 million in gross equity and restructured over $9.3 million of secured debt 12. Revenue increased 39% Also most importantly the Patent Approval!!! $IDXG European Patent Decision data.epo.org ALSO FULL YEAR HIGHLIGHTS READ HERE: ih.advfn.com
ILong
by StockGuild
THE WEEK AHEAD: SNAP, FEZ, XLV, AND XRTWith four weeks or so until the next batch of earnings, I'm briefly turning my attention to exchange-traded funds to see if there's anything I can play to bridge the gap between earnings seasons. As with the previous several weeks, there isn't much; only three are near or above the 70th percentile for implied volatility over the past six months: FEZ, with an implied volatility rank of 86, and a background implied volatility of 20; XLV (68/17) (no surprise there; some friskiness associated with the failed Repeal and Replace measure); and XRT (67/22). I will look to work XLV and XRT with iron flies, possibly, but I may go directional on FEZ, since it's meant to replicate the performance of the Euro Stoxx 50. The other possibility is SNAP. It hasn't been on the block long enough for it to have a "6 month" metric of anything, but its background implied volatility is at 59%, and that's somewhat high for this market. Because of its potential for rippage, I think the best play in that is directional or where there is no directional risk on one side or the other (put diagonal, Jade Lizard, Big Liz). I'll putz with possible SNAP setups here and post separately if something looks particularly attractive ... .
NYSE:SNAP
by NaughtyPines
2
TRADE IDEA: A SNAP POOR MAN'SOne thing I'm certain about, and that's that I don't want to buy SNAP stock here with its having whipsawed between 29+ and 19 in the short time since its IPO. But I might want to acquire it later once it settles down -- as with all things, preferably at a lower price than 22.74. A Poor Man's Covered Call gives me the flexibility to play SNAP, give me the option to buy it later by exercising the 15 long call before expiry, as well as to reduce cost basis in that long call while I'm waiting for it to figure out where it's going. Consequently, here I'm thinking a Poor Man's Covered Call where the long-dated, back month, long option takes the place of long stock and (as with any covered call), the short call looks to reduce cost basis in the long option, while protecting the position from some downside. As with a covered call, you look to roll out the short option for duration, ideally keeping it clear of your cost basis, and you exit the trade for a credit that exceeds what you paid to put it on minus any credits collected due to rolling. Metrics: Max Loss/Buying Power Effect: $725/contract Theta: 2.23/contract Delta: 50.38 As with any diagonal (that's what this is, basically), we don't know much else about the setup in terms of potential profit, but I generally look to exit these north of 10% of what I paid to put them on. Naturally, this is likely to continue to be somewhat of a roller coaster, so you need to be prepared for somewhat of a bumpy ride, particularly as price moves toward the long call side of the setup (since its delta long). Notes: There is some piddling that needs to be done with these to ensure that the credit received for the short call exceeds any extrinsic value in the long option. The extrinsic value in the long option can be calculated by subtracting the difference between current price and the long call strike from what you will be paying for the long option 8.20 - (22.74 - 15) = .46. The April 21st 24 short call brings in .95 in credit at the mid, which is greater than the extrinsic value in the long. Currently, the long option is bid 7.80/ask 8.60, so some further adjustment may be required during regular market hours to recalculate whether the extrinsic value received for the short exceeds that in the long and/or to get a fill.
NYSE:SNAPLong
by NaughtyPines